Ovarian Cancer Flashcards
Prognosis
5YR SURVIVAL ALL STAGES = 30%
MOST PRESENT w/ ADVANCED DISEASE - STAGE 3/4 DISEASE
Aetiology
MAINLY = likely originate from FALLOPIAN TUBES
SOME = derive from PRE-EXISTING BENIGN OVARIAN CYSTS (ofeten low grade cancers)
Presentation
- VAGUE!
- INDIGESTION/EARLY SATIETY/POOR APPETITE
- ALTERED BOWEL HABIT/PAIN - pelvic/abdominal
- BLOATING/DISCOMFORT/WGT. GAIN○ Can have similar symptoms to IBS - but IBS RARELY PRESENTS for 1ST in WOMEN of this AGE
○ ASYMPTOMATIC ○ PRESSURE SYMPTOMS
• Sometimes URINARY SYMPTOMS
Investigations
SURGICAL/PATHOLOGICAL
* PELVIC EXAM * USS ABDOMEN & PELVIS * CT SCAN * CA 125 * SURGERY
Management
• SURGERY + ADJUVANT CHEMOTHERAPY (gold standard) - neoadjuvant chemotherapy to shrink/remove small tumours
Laparotomy = OBTAIN TISSUE DIAGNOSIS + STAGE DISEASE + DISEASE CLEARANCE/DEBULK DISEASE
Chemotherapy = 1st line is platinum + taxane (taxol) w/I 8 weeks of surgery - complete/partial surgery, avg response if 2yrs - may have to re-challenge
Recurrence = chemotherapy (platinum if < 6 months), palliation, surgery in highly selective pt.
Epidemiology/Risk Factors
- RARE < 30YRS
- ≥ 50s
○ Tend to PRESENT DECADE EARLY ~ 40s - MID-40s
- INCESSANT OVULATION
- OCP PROTECTIVE
Staging
1 = limited to ovaries w/ capsule intact
2 = 1/both ovaries w/ pelvic extension
3 = 1/both ovaries w/ omental disease/lymph node involvement
4 = distant metastasis
Ovarian Cancer Screening
not recommended for normal pt. as low sensitivity + low specificity
high risk women = cancer gene mutation carriers/≥ 2 relatives = pelvic examination, USS ovaries, CA 125; can have prophylactic oophorectomy
CA 125
detecting + monitoring epithelial ovarian tumours
benign = endometriosis, menstruation, PID, liver disease, recent surgey, effusions - raised in peritoneal inflammation
malignant = ovary, breast, colon/pancreas